| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology, Pathobiology, and Genetics |
1 Neuro-Oncology Branch, National Cancer Institute; 2 National Institutes of Neurological Disorder and Stroke, NIH, Bethesda, Maryland and 3 Departments of Neurology and Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, Michigan
Requests for reprints: Jean C. Zenklusen, Neuro-Oncology Branch, National Cancer Institute, 37 Convent Drive, Room 1142B, Bethesda, MD 20892-4254. Phone: 301-451-2144; Fax: 301-480-4743; E-mail: jz44m{at}mail.nih.gov.
Primary brain tumors are the fourth leading cause of cancer mortality in adults under the age of 54 years and the leading cause of cancer mortality in children in the United States. Therapy for the most common type of primary brain tumors, gliomas, remains suboptimal. The development of new and more effective treatments will likely require a better understanding of the biology of these tumors. Here, we show that use of the high-density 100K single-nucleotide polymorphism arrays in a large number of primary tumor samples allows for a much higher resolution survey of the glioma genome than has been previously reported in any tumor type. We not only confirmed alterations in genomic areas previously reported to be affected in gliomas, but we also refined the location of those sites and uncovered multiple, previously unknown regions that are affected by copy number alterations (amplifications, homozygous and heterozygous deletions) as well as allelic imbalances (loss of heterozygosity/gene conversions). The wealth of genomic data produced may allow for the development of a more rational molecular classification of gliomas and serve as an important starting point in the search for new molecular therapeutic targets. (Cancer Res 2006; 66(19): 9428-36)
This article has been cited by other articles:
![]() |
S. Waaijenborg and A. H. Zwinderman Correlating multiple SNPs and multiple disease phenotypes: penalized non-linear canonical correlation analysis Bioinformatics, November 1, 2009; 25(21): 2764 - 2771. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Q. Qu, K. Jacob, S. Fatet, B. Ge, D. Barnett, O. Delattre, D. Faury, A. Montpetit, L. Solomon, P. Hauser, et al. Genome-wide profiling using single-nucleotide polymorphism arrays identifies novel chromosomal imbalances in pediatric glioblastomas Neuro Oncology, October 15, 2009; (2009) nop001v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bicciato, R. Spinelli, M. Zampieri, E. Mangano, F. Ferrari, L. Beltrame, I. Cifola, C. Peano, A. Solari, and C. Battaglia A computational procedure to identify significant overlap of differentially expressed and genomic imbalanced regions in cancer datasets Nucleic Acids Res., August 1, 2009; 37(15): 5057 - 5070. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Yin, S. Ogawa, N. Kawamata, P. Tunici, G. Finocchiaro, M. Eoli, C. Ruckert, T. Huynh, G. Liu, M. Kato, et al. High-Resolution Genomic Copy Number Profiling of Glioblastoma Multiforme by Single Nucleotide Polymorphism DNA Microarray Mol. Cancer Res., May 1, 2009; 7(5): 665 - 677. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Rong, V. E. Belozerov, C. Tucker-Burden, G. Chen, D. L. Durden, J. J. Olson, E. G. Van Meir, N. Mackman, and D. J. Brat Epidermal Growth Factor Receptor and PTEN Modulate Tissue Factor Expression in Glioblastoma through JunD/Activator Protein-1 Transcriptional Activity Cancer Res., March 15, 2009; 69(6): 2540 - 2549. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Li, J. Walling, S. Ahn, Y. Kotliarov, Q. Su, M. Quezado, J. C. Oberholtzer, J. Park, J. C. Zenklusen, and H. A. Fine Unsupervised Analysis of Transcriptomic Profiles Reveals Six Glioma Subtypes Cancer Res., March 1, 2009; 69(5): 2091 - 2099. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kotliarov, S. Kotliarova, N. Charong, A. Li, J. Walling, E. Aquilanti, S. Ahn, M. E. Steed, Q. Su, A. Center, et al. Correlation Analysis between Single-Nucleotide Polymorphism and Expression Arrays in Gliomas Identifies Potentially Relevant Target Genes Cancer Res., February 15, 2009; 69(4): 1596 - 1603. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Hodgson, R.-F. Yeh, A. Ray, N. J. Wang, I. Smirnov, M. Yu, S. Hariono, J. Silber, H. S. Feiler, J. W. Gray, et al. Comparative analyses of gene copy number and mRNA expression in glioblastoma multiforme tumors and xenografts Neuro-oncol, January 1, 2009; 11(5): 477 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. Purow, T. K. Sundaresan, M. J. Burdick, B. A. Kefas, L. D. Comeau, M. P. Hawkinson, Q. Su, Y. Kotliarov, J. Lee, W. Zhang, et al. Notch-1 regulates transcription of the epidermal growth factor receptor through p53 Carcinogenesis, May 1, 2008; 29(5): 918 - 925. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lee, S. W. Kong, and P. J. Park Integrative analysis reveals the direct and indirect interactions between DNA copy number aberrations and gene expression changes Bioinformatics, April 1, 2008; 24(7): 889 - 896. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Rigaill, P. Hupe, A. Almeida, P. La Rosa, J.-P. Meyniel, C. Decraene, and E. Barillot ITALICS: an algorithm for normalization and DNA copy number calling for Affymetrix SNP arrays Bioinformatics, March 15, 2008; 24(6): 768 - 774. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kuga, M. Mizoguchi, Y. Guan, N. Hata, K. Yoshimoto, T. Shono, S. O. Suzuki, Y. Kukita, T. Tahira, S. Nagata, et al. Prevalence of copy-number neutral LOH in glioblastomas revealed by genomewide analysis of laser-microdissected tissues Neuro-oncol, January 1, 2008; 10(6): 995 - 1003. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Li, J. Walling, Y. Kotliarov, A. Center, M. E. Steed, S. J. Ahn, M. Rosenblum, T. Mikkelsen, J. C. Zenklusen, and H. A. Fine Genomic Changes and Gene Expression Profiles Reveal That Established Glioma Cell Lines Are Poorly Representative of Primary Human Gliomas Mol. Cancer Res., January 1, 2008; 6(1): 21 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Beroukhim, G. Getz, L. Nghiemphu, J. Barretina, T. Hsueh, D. Linhart, I. Vivanco, J. C. Lee, J. H. Huang, S. Alexander, et al. Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma PNAS, December 11, 2007; 104(50): 20007 - 20012. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. B. Furnari, T. Fenton, R. M. Bachoo, A. Mukasa, J. M. Stommel, A. Stegh, W. C. Hahn, K. L. Ligon, D. N. Louis, C. Brennan, et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment Genes & Dev., November 1, 2007; 21(21): 2683 - 2710. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kamnasaran, B. Qian, C. Hawkins, W. L. Stanford, and A. Guha From the Cover: GATA6 is an astrocytoma tumor suppressor gene identified by gene trapping of mouse glioma model PNAS, May 8, 2007; 104(19): 8053 - 8058. [Abstract] [Full Text] [PDF] |
||||
![]() |
Correction: Genomic Survey of Gliomas Cancer Res., March 1, 2007; 67(5): 2389 - 2389. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |